Saltar ao contenido
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avanzado
  • IMMUNOLOGICAL CONSEQUENCES AND...
  • Citar
  • Text this
  • Enviar este rexistro por email
  • Imprimir
  • Exportar rexistro
    • Exportar a RefWorks
    • Exportar a EndNoteWeb
    • Exportar a EndNote
  • Permanent link
IMMUNOLOGICAL CONSEQUENCES AND TRAFFICKING OF HUMAN REGULATORY MACROPHAGES ADMINISTERED TO RENAL TRANSPLANT RECIPIENTS

IMMUNOLOGICAL CONSEQUENCES AND TRAFFICKING OF HUMAN REGULATORY MACROPHAGES ADMINISTERED TO RENAL TRANSPLANT RECIPIENTS

Detalles Bibliográficos
Main Authors: Hutchinson, J, Riquelme, P, Sawitzki, B, Tomiuk, S, Miqueu, P, Zuhayra, M, Oberg, H, Pascher, A, Luetzen, U, Janssen, U, Broichhausen, C, Renders, L, Thaiss, F, Scheuermann, E, Henze, E, Volk, H, Chatenoud, L, Lechler, R, Wood, K, Kabelitz, D, Schlitt, H, Geissler, E, Faendrich, F
Formato: Journal article
Publicado: 2011
  • Existencias
  • Descripción
  • Títulos similares
  • Staff View

Títulos similares

  • Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients.
    por: Hutchinson, J, et al.
    Publicado: (2011)
  • Cutting edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients
    por: Hutchinson, J, et al.
    Publicado: (2011)
  • In question: the scientific value of preclinical safety pharmacology and toxicology studies with cell-based therapies
    por: Christiane Broichhausen, et al.
    Publicado: (2014-01-01)
  • Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial.
    por: Ondrej Viklicky, et al.
    Publicado: (2017-01-01)
  • TIGIT+ iTregs elicited by human regulatory macrophages control T cell immunity
    por: Paloma Riquelme, et al.
    Publicado: (2018-07-01)

Opciones de procura

  • Historial de Procuras
  • Procura avanzada

Buscar Máis

  • Revisar o catálogo
  • Lista alfabética
  • Explore Channels
  • Reservas de curso
  • Novos exemplares

Necesita Axuda?

  • Consello de procura
  • Consulte a un Bibliotecario
  • Preguntas Frecuentes